Search

everythinglearnresearchcommunity

for

Search:↓

Megavoltage radiation therapy extended survival in rabbits with thymomas, especially in those weighing more than 1.57 kg.

Oxidative stress and immune dysfunction are linked to both Hashimoto's thyroiditis and polycystic ovary syndrome, with diet and specific treatments important for managing these conditions.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Transgender men on testosterone therapy need ongoing gynecologic care due to potential cancer risks.

A woman's adrenal tumor disappeared after treatment with cyproterone acetate.

Hair loss is a common side effect of hormone treatments for cancer.

Using GnRHa agonists helps diagnose and treat ovarian hyperthecosis when surgery isn't possible.

Hidden sweat gland tumors might cause hair loss.

A woman with a rare adrenal tumor and hormonal disorder had improved testosterone levels after surgery, but her menstrual irregularities continued.

Iron supplements may improve hair loss satisfaction even if initial iron levels are normal.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

More research is needed to understand chemotherapy-induced hair loss and its phases.

A rare case of Cushing syndrome was successfully treated with one-sided adrenal gland removal, suggesting personalized treatment is important.

A woman's masculine symptoms were caused by an ovarian tumor, which improved after surgery.

Inflammation and metabolic changes are linked to postpartum hair loss after a first C-section.

Endocrine diseases in dogs often cause skin problems, with hypothyroidism and hyperadrenocorticism being common and leading to hair loss and infections.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Low-dose oral contraceptives reduced hair growth and testosterone levels in women with polycystic ovary syndrome.

The document concludes that most patients with endocrine disorders experience diffuse, non-scarring hair loss, with scarring hair loss being rare.

A man's rare adrenal tumor caused feminization and white hair, was removed surgically, and improved after treatment.

Testosterone therapy can improve skin and hair in men with low testosterone but may cause skin irritation with certain treatments.

Glucocorticoid treatment lowered androgen levels but didn't improve hirsutism or ovulation and caused weight gain.

Scalp hypothermia can prevent chemotherapy-induced hair loss but is not suitable for all patients, and more research is needed to improve prevention methods.

Some men lost hair after deoxycholic acid treatment for neck fat, but most saw improvement or resolution.

Hair loss from immunosuppressive drugs in transplant patients can affect well-being and treatment adherence, so personalized management is important.

Tacrolimus treatment for autoimmune hepatitis can cause hair loss.

A young woman had a rare tumor causing high male hormone levels and symptoms like excessive hair and acne. After removing the tumor, her hormone levels returned to normal. Early diagnosis is important.

A young woman with kidney failure had hair loss due to a common hormonal disorder, which improved with hormone therapy.

RET mutation is important in familial medullary thyroid carcinoma, and BRAF mutation in papillary thyroid carcinoma is linked to more aggressive cancer and higher death rates.

Treatment restored normal sexual characteristics and blood condition in a patient with testicular cancer.